Neuronetics Newsroom

JMP Securities Maintains Neuronetics(STIM.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsNov 14 01:31 ET

JMP Securities Maintains Neuronetics(STIM.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsNov 13 17:31 ET

Neuronetics' Strategic Merger With Greenbrook TMS: A Buy Rating Amidst Revenue Challenges and Anticipated Synergies

TipRanksNov 13 17:16 ET

CCORF Maintains Neuronetics(STIM.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsNov 13 08:36 ET

Neuronetics Analyst Ratings

BenzingaAug 14 14:00 ET

JMP Securities Maintains Neuronetics(STIM.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsAug 14 00:31 ET

CCORF Maintains Neuronetics(STIM.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsAug 13 07:32 ET

William Blair Downgrades Neuronetics(STIM.US) to Hold Rating

Moomoo NewsAug 13 06:35 ET

Neuronetics Analyst Ratings

BenzingaAug 12 18:24 ET

Neuronetics Analyst Ratings

BenzingaMay 14 09:07 ET

Strong Buy Rating for Neuronetics Backed by Solid Financials and Growth Prospects

TipRanksMay 8 07:36 ET

Buy Rating on Neuronetics: Solid Fundamentals and Growth Despite Challenges

TipRanksMay 8 01:10 ET

Buy Rating for Neuronetics Amid FDA Clearance and Expanding Adolescent MDD Market

TipRanksMar 26 07:20 ET

Neuronetics Analyst Ratings

BenzingaMar 6 09:30 ET

Piper Sandler Sticks to Their Buy Rating for Neuronetics (STIM)

TipRanksMar 6 07:40 ET

Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Marinus (MRNS) and Gritstone Oncology (GRTS)

TipRanksMar 6 00:35 ET

Neuronetics Stock Receives Buy Rating From Canaccord Genuity Amid Strong Q4 Performance and Positive Outlook

TipRanksJan 9 07:53 ET

Positive Q3 Results and Commercial Initiatives Drive Plovanic's Buy Rating on Neuronetics (STIM)

TipRanksNov 8, 2023 07:53 ET

Promising Growth and Strategic Advancements: A Buy Rating for Neuronetics

TipRanksNov 8, 2023 01:13 ET

Neuronetics (STIM) Receives a Buy From JMP Securities

TipRanksAug 9, 2023 01:25 ET